Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non–vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage

IMPORTANCE: Current guidelines recommend the use of non–vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in patients with atrial fibrillation (AF). Data regarding warfarin sodium use compared with NOAC use in patients with AF with a history of intracranial hemorrhage (ICH) are...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Chuan-Tsai, Liao, Jo-Nan, Chiang, Chern-En, Lin, Yenn-Jiang, Chang, Shih-Lin, Lo, Li-Wei, Hu, Yu-Feng, Tuan, Ta-Chuan, Chung, Fa-Po, Chao, Tze-Fan, Lip, Gregory Y. H., Chen, Shih-Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265096/
https://www.ncbi.nlm.nih.gov/pubmed/32478848
http://dx.doi.org/10.1001/jamanetworkopen.2020.6424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265096/
https://www.ncbi.nlm.nih.gov/pubmed/32478848
http://dx.doi.org/10.1001/jamanetworkopen.2020.6424

Ejemplares similares